Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Operating activities:    
Net income (loss) $ 14,049 $ (8,123)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Depreciation and amortization 5,194 4,950
Stock-based compensation 1,763 820
CARES Act loan forgiveness (8,561)  
Amortization of debt issuance costs 265 232
Deferred taxes 120 (3,899)
Changes in operating assets and liabilities:    
Accounts receivable (794) 5,886
Inventory (181) 748
Other current assets (210) (423)
Due from related parties   (35)
Security deposits (26) 315
Other assets (85) (863)
Accounts payable 2,356 (1,602)
Accrued expenses 7,596 (2,534)
Operating lease liabilities and right-of-use assets 29 538
Deferred gift card and license revenue (1,671) (937)
Net cash provided by (used in) operating activities 19,844 (4,927)
Investing activities:    
Purchase of property and equipment (5,373) (1,681)
Net cash used in investing activities (5,373) (1,681)
Financing activities:    
Proceeds from CARES Act Loans   18,314
Repayments of long-term debt (321) (433)
Debt issuance costs (41) (50)
Exercise of stock options and warrants 3,151 38
Tax-withholding obligation on stock based compensation (154) (90)
Purchase of non-controlling interests (75)  
Net cash provided by financing activities 2,560 17,779
Effect of exchange rate changes on cash (9) (55)
Net increase in cash and cash equivalents 17,022 11,116
Cash and cash equivalents, beginning of period 24,385 12,344
Cash and cash equivalents, end of period 41,407 23,460
Supplemental disclosure of cash flow data:    
Interest paid 2,076 1,770
Income taxes paid 53 106
Non-cash CARES Act loan forgiveness $ 8,561  
Non-cash property and equipment additions   $ 303